Acadia Pharmaceuticals Inc. is a biopharmaceutical company focused on discovering and commercializing medicines for central nervous system and neurological disorders. The company's commercial portfoli... Acadia Pharmaceuticals Inc. is a biopharmaceutical company focused on discovering and commercializing medicines for central nervous system and neurological disorders. The company's commercial portfolio includes NUPLAZID, the first and only FDA-approved treatment for hallucinations and delusions associated with Parkinson's disease psychosis, and DAYBUE, an FDA-approved treatment for Rett syndrome available in oral solution and powder formulation (DAYBUE STIX). Acadia maintains a robust pipeline addressing significant unmet medical needs, with mid- to late-stage programs in development for Alzheimer's disease psychosis and Lewy body dementia psychosis, alongside earlier-stage neurological and rare disease programs. Founded in 1993 and headquartered in San Diego, California, the company serves patients, healthcare providers, and the global medical community by advancing therapeutic options for underserved patient populations in neurological and rare disease segments.Show lessShow more

Disclosures ESG Data Financial Data

GHG Emissions Climate Targets EU Taxonomy Energy Waste Management

Data not available

ACADIA Pharmaceuticals is not subject to EU Taxonomy reporting

Based on current regulatory requirements, ACADIA Pharmaceuticals is not required to report EU Taxonomy data under the CSRD framework. As a result, we have not conducted a detailed EU Taxonomy data review for this company.

If you believe this assessment should be revisited, you may submit a data coverage request and our team will review the company's regulatory applicability.

Would you like us to review ACADIA Pharmaceuticals's data?

Start your 30-day free trial to request a data review for ACADIA Pharmaceuticals.

Start Free Trial

Legal Center Contact Us

ACADIA Pharmaceuticals Inc

ACADIA Pharmaceuticals is not subject to EU Taxonomy reporting

Account Restricted